Learn More
Medchemexpress LLC Xmu-mp-3 | 2031152-08-4 | 95.7% | C27H27F3N8O | 10MG

Supplier: Medchemexpress LLC HY13653110MG
XMU-MP-3 is a potent, non-covalent inhibitor of Bruton's tyrosine kinase (BTK) that inhibits both wild-type BTK and the C481S mutant. It demonstrates low-nanomolar biochemical potency and cellular activity, including induction of apoptosis, and is suitable for biochemical and cellular studies of BTK signaling and inhibitor profiling.
- Low-nanomolar biochemical potency (IC50 10.7 nM for BTK WT, 17.0 nM for BTK C481S in the presence of 10 μM ATP).
- Demonstrated cellular activity (BTK-transformed Ba/F3 proliferation IC50 11.4 nM).
- Induces apoptosis in BTK-dependent cell models.
- High chemical purity (95.7%).
- Defined storage stability for powder and solutions.
- Suitable for biochemical assays and cellular mechanistic studies.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.